Tcw Group Inc Acadia Pharmaceuticals Inc Transaction History

Tcw Group Inc

  • $11.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 23, 2021
SELL
$19.4 - $27.42 $202,729 - $286,539
-10,450 Closed
0 $0
Q1 2021

May 05, 2021
SELL
$25.02 - $54.99 $1,901 - $4,179
-76 Reduced 0.72%
10,450 $270,000
Q4 2020

Feb 02, 2021
BUY
$41.04 - $56.79 $431,987 - $597,771
10,526 New
10,526 $563,000

Others Institutions Holding ACAD

# of Institutions
291
Shares Held
159M
Call Options Held
723K
Put Options Held
270K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.85B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Tcw Group Inc Portfolio

Follow Tcw Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email